Streetbeat News

Revenues

FSLY

Fastly (NYSE:FSLY) has been analyzed by 8 analysts in the last quarter, showing a range of opinions from bullish to bearish. The average 12-month price target is now $13.06, down 35.63% from the previous $20.29, indicating a downward trend in expectations. Analysts from firms including Citigroup, RBC Capital, DA Davidson, B of A Securities, Piper Sandler, and Craig-Hallum have adjusted their ratings and price targets, reflecting a cautious or negative outlook on Fastly's performance. Despite this, Fastly shows a positive revenue trend with a growth rate of 15.47% as of December 31, 2023, but its market capitalization is below industry averages, and it has a net margin of -16.97%.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 7:01 pm

VECO

Veeco Instruments (NASDAQ:VECO) has received mixed analyst ratings over the past three months, with 6 analysts offering evaluations. The sentiment has shifted positively, with the average 12-month price target rising to $39.67, up 12.28% from the previous $35.33. Analysts from firms including Goldman Sachs, Barclays, Needham, Citigroup, and Benchmark have raised their price targets, reflecting optimism about the company's financial performance and market position. Veeco Instruments, a company engaged in manufacturing thin-film process equipment, has shown a positive revenue trend with a growth rate of 13.09% and a notable net margin of 12.44%, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 7:01 pm

IMXI

Analyst ratings for IntL Money Express (NASDAQ:IMXI) show a mix of bullish and somewhat bullish views, with recent adjustments in price targets and ratings. The average 12-month price target is now $27.75, down from $29.50, indicating a 5.93% decrease. Analysts from BMO Capital and Needham, among others, have updated their ratings and price targets, reflecting their perspectives on the company's performance and market conditions. IntL Money Express, a money transfer service provider to Latin America and the Caribbean, has shown notable revenue growth and profitability, with a revenue growth rate of 10.35% and a net margin of 10.36%, but carries a higher debt-to-equity ratio of 1.45 compared to industry averages.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 7:00 pm

MEG

Six analysts have recently provided diverse ratings for Montrose Environmental Gr (NYSE:MEG), with a consensus leaning towards bullish. Over the last three months, the sentiment has shifted positively, with the latest 12-month price target averaging $51.33, marking a significant increase from the previous $41.67. This adjustment reflects a 23.18% rise in the average price target, influenced by recent analyst actions including ratings maintenance and target raises by firms such as Needham and Stifel. Montrose Environmental Gr's financial performance shows an 18.8% revenue growth rate, a net margin of -3.34%, and a debt-to-equity ratio of 0.65, indicating strong revenue growth and prudent financial management despite a below-average ROE and ROA.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 7:00 pm

BMBL

Bumble Inc. (NASDAQ:BMBL) shares surged over 12% after reporting Q1 2024 earnings that exceeded expectations. EPS was 19 cents, beating estimates by 171.43%, and sales reached $267.77 million, surpassing forecasts. The company saw a 10.2% revenue increase, with Bumble App revenue up by 11.1%. Bumble anticipates Q2 revenue between $269 million and $275 million, with full-year 2024 targets of 8% to 11% revenue growth. Analysts from Evercore ISI Group, Goldman Sachs, and Deutsche Bank provided mixed price target adjustments.

Portfolio Pulse from Vaishali Prayag

May 09, 2024 | 6:26 pm

GMED

Globus Medical (NYSE:GMED) received varied analyst ratings in the last quarter, with a shift towards more bullish views in the last 30 days. The average 12-month price target for GMED is now $66.00, up from $63.50, indicating a positive outlook from analysts. The company has shown significant revenue growth of 124.6% as of December 31, 2023, but faces challenges in profitability and efficiency, with below-average net margin, ROE, and ROA. Despite these challenges, GMED's debt management is strong, with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 6:01 pm

CCCC

C4 Therapeutics (NASDAQ:CCCC) received mixed analyst ratings with a recent shift towards a more positive outlook, as evidenced by updated price targets and ratings from analysts at Wells Fargo, Stifel, and Morgan Stanley. The average 12-month price target for CCCC has been raised to $10.75, indicating a 30.3% increase from the previous target. This change reflects analysts' adapting recommendations based on market conditions and C4 Therapeutics' performance, including its financials showing revenue growth but challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 6:01 pm

NRDY

In the last three months, Nerdy (NYSE:NRDY) received mixed analyst ratings, with a shift towards a more positive outlook in recent evaluations. The average 12-month price target for NRDY has been raised to $4.19 from $3.25, indicating a 28.92% increase. Analysts from Goldman Sachs, Needham, and JP Morgan have updated their ratings and price targets, reflecting changes in market conditions and Nerdy's performance. Despite a lower market capitalization and challenges in profitability, Nerdy has shown impressive revenue growth of 31.77% as of December 31, 2023, surpassing industry averages in the Consumer Discretionary sector.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 6:01 pm

CXW

Recent analyst ratings for CoreCivic (NYSE:CXW) show a unanimous somewhat bullish outlook, with four analysts maintaining an 'Outperform' rating. The 12-month price target has been raised to an average of $18.75, indicating a 7.14% increase from the previous target of $17.50. CoreCivic's financial performance shows a revenue growth of 4.2% for the last quarter of 2023, but it trails behind industry averages in net margin, ROE, and ROA, indicating potential challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 6:00 pm

GXO

GXO Logistics (NYSE:GXO) has been the subject of 7 analyst ratings over the past three months, showing a mix of bullish to bearish sentiments. The average 12-month price target has been adjusted to $70.00, a decrease from the previous $73.33. Analyst actions include both upgrades and downgrades, with price targets ranging from $50.00 to $82.00. GXO's financial performance is strong, with revenue growth, net margin, ROE, and ROA all surpassing industry benchmarks. The company's market capitalization is below industry standards, but it maintains a balanced debt approach.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 6:00 pm